New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Avadel Pharmaceuticals plc
AVDL
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

1B

Drug Manufacturers - Specialty & Generic

Next Earning date - 13 Nov 2024

1B

Drug Manufacturers - Specialty & Generic

Next Earning date - 13 Nov 2024

13.22USD
Shape-0.46 ( -3.36%)
favorite-chart

Relative Strenght

88
favorite-chart

Volume Buzz

-2%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

31%

Quote Panel

Shape
Updated October 24, 2024
1W -2.65 % 1M 4.10 % 3M -18.91 % 1Y 37.03 %

Key Metrics

Shape
  • Market Cap

    1.27B


  • Shares Outstanding

    96.27M


  • Share in Float

    90.35M


  • Dividende

    0


  • Earning Date

    13 Nov 2024


  • Price Target

    13.22


  • Average Volume

    916565


  • Beta

    1.632


  • Range

    9.5-19.09


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://www.avadel.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

13.38x

P/S Ratio

18.08x

P/B Ratio

0.5

Debt/Equity

-111.6%

Net Margin

$-1.1

EPS

How AVDL compares to sector?

P/E Ratio

Relative Strength

Shape

AVDL

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$300M

Shape624%

2025-Revenue

$0.56

Shape499%

2025-EPS

$15M

Shape-18%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Rodman & Renshaw

initialise

Previous: Not converted

2024-06-11

Now: Buy

Jefferies

downgrade

Previous: Not converted

2022-08-09

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.33
vs -0.38

Q4.22

arrow
arrow

N/A

-0.44
vs -0.38

Q1.23

arrow
arrow

N/A

-0.48
vs -0.45

Q2.23

arrow
arrow

N/A

-0.70
vs -0.50

Q3.23

arrow
arrow

N/A

-0.41
vs -0.33

Q4.23

arrow
arrow

N/A

-0.32
vs -0.44

Q1.24

arrow
arrow

N/A

-0.30
vs -0.48

Q2.24

arrow
arrow

N/A

-0.14
vs -0.70

Q3.24

arrow
arrow

N/A

-0.08
vs -0.41

Q4.24

arrow
arrow

N/A

-0.02
vs -0.32

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

NA

NA  vs NA

Q4.22

arrow
arrow

NA

NA  vs NA

Q1.23

arrow
arrow

NA

NA  vs NA

Q2.23

arrow
arrow

NA

1.5M  vs NA

Q3.23

arrow
arrow

NA

7M  vs NA

Q4.23

arrow
arrow

NA

19.5M  vs NA

Q1.24

arrow
arrow

NA

27.2M  vs NA

Q2.24

arrow
arrow

+2674%

41.5M  vs 1.5M

Q3.24

arrow
arrow

+591%

48.4M  vs 7M

Q4.24

arrow
arrow

+188%

56.1M  vs 19.5M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

+162%

1.62
vs 19.04

Q4.22

arrow
arrow

+130%

1.3
vs 1.62

Q1.23

arrow
arrow

+81%

0.81
vs 1.3

Q2.23

arrow
arrow

-45%

-0.45
vs 0.81

Q3.23

arrow
arrow

-33%

-0.33
vs -0.45

Q4.23

arrow
arrow

-33%

-0.33
vs -0.33

Q1.24

arrow
arrow

-35%

-0.35
vs -0.33

Q2.24

arrow
arrow

-20%

-0.20
vs -0.35

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

83

83
vs 86

-3%

Q4.22

arrow
arrow

97

97
vs 83

17%

Q1.23

arrow
arrow

100

100
vs 97

3%

Q2.23

arrow
arrow

111

111
vs 100

11%

Q3.23

arrow
arrow

109

109
vs 111

-2%

Q4.23

arrow
arrow

122

122
vs 109

12%

Q1.24

arrow
arrow

132

132
vs 122

8%

Q2.24

arrow
arrow

10

10
vs 132

-92%

Earnings Growth

Latest News